Home > about TAEJOON > History

Signed a supply agreement of Xalost for China
Utilized mSFA(Mobile Sales Force Automation)
Successfully defended in a lawsuit GE ArmorSham VS Taejoon
Signed a supply agreement of Xalost with AZAD, Switzerland for EU market
Transferred R&D Central to the Biocenter in Gyeounggi Province
Selected one of the occupants of the Pan-Gyo Techno-Valley
Held the 2nd Molecular and Advanced Imaging in NanoBiomedical Practice Symposium

Completed cGMP level plant in YongIn
Established sales and marketing company Accuzen, Inc. for Contrast media & Adjuvant for Radiology

Developed generic Glaucoma agent, Xalost first in Korea

Celebrates the 27th anniversary of Foundation
Holds 'Medical Application of Nano Technology and Molecular Imaging' International symposium
Awarded as Sincere Tax Payer (The Minister of Finance and Economy)


Retina vein obstacle cure agents QRETIN introduced
Anti-Ulcer agents REBAMIPID Tab. introduced
Invites Dr. Edmund Kim (M.D. Anderson Cancer Center),
Dr. YoungHo Oh(Cornell University) as Medical Advisory Committee


Antifungal agents NEOCONAL introduced
Participates in RSNA (Radiological Society of North America)
Signs a contract with AMI for the introducing of COMBIDEX exclusively


Holds Grand Symposium at Scientific Conference of Korea Ophthalmological Society
MRI Contrast Media MRBester developed
Introduces Contrast Media in 3 different fields; CT, MRI, UGI first in the world.
Supports Pyong-yang Lions Ophthalmic Hospital with pharmaceuticals supplies
Exports contrast media products to 8 countries in Central & South America
Opens cGMP Plants meets American FDA standards first in Korea
Participates in RSNA (Radiology society of North America)
Improved new ophthalmic agent AZELAN introduced


Sings a contract with Nippon Shinyaku to exclusively introduce GASLON-N, gastric ulcer agent
Institutes 1st Taejoon Ophthalmology Thesis Award
Institutes 1st TaeJoon Ophthalmology Service Award
Institutes a Taejoon Radiological Award (The Korean Radiological Society)






Introduces 6 ophthalmic agents at the same time
 - TORAVIN Ophthalmic Solution/ Ointment (Antibiotics)
 - POVIRON Ophthalmic Solution (Artificial tears)
 - OFENAC Ophthalmic Solution (Antiinflammatory agents)
 - KETOVIN Ophthalmic Solution (Antiallergic agents)
 - CATELON Ophthalmic Solution (Agents for Glaucoma)
Develops the ophthalmic agent container inscribed in Braille Points for the visually challenged.
President Tae Young Lee appointed as Vice President of “Blindness Prevention Committee?/td>
Sets up management equipment Solution eTPM
Makes the record of Undisaster 5 times recording achievement
(Korea Occupational Safety & Health Agency)
Selected as model company for organization improvement (Small Business Corporation)
Selected as Venture company(Seoul Regional Office Small & Medium Business Administration)